<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1615341/" ref="ordinalpos=1902&amp;ncbi_uid=890798&amp;link_uid=PMC1615341" image-link="/pmc/articles/PMC1615341/figure/F9-4036/" class="imagepopup">Figure 9.  From: Advanced Glycation End Products Induce Tubular Epithelial-Myofibroblast Transition through the RAGE-ERK1/2 MAP Kinase <span class="highlight" style="background-color:">Signaling</span> <span class="highlight" style="background-color:">Pathway</span>. </a></div><br /><div class="p4l_captionBody">Western blot analysis demonstrates that AGEs signal through RAGE to activate the ERK1/2 signaling pathway. <b>a:</b> A representative Western blot shows that AGE-BSA (30 Î¼g/ml) induces ERK1/2 phosphorylation in NRK52E in a time-dependent manner, being significant at 15 minutes. <b>b:</b> AGEs, but not BSA, induce ERK1/2 phosphorylation (at 30 minutes) in a dose-dependent manner and this is blocked by both sRAGE and a specific ERK1/2 inhibitor, PD 98059. Each sample represents the results from three independent experiments.</div></div>